Medtronic (NYSE: MDT) announced today that it received CE mark for its ColonPRO fourth-generation software for AI-assisted colonoscopy.

For GI clinics and ASCs, accurate coding and documentation are critical to protecting reimbursement, reducing denials and ...

New FDA-cleared version with tool detection and CE-marked version with additional quality (CAQ) features further strengthen MAGENTIQ-COLO™'s AI platform HAIFA, IL / ACCESS Newswire / January 26, ...

Abstract: For this research, a comparison was done between the state of the art models ConvNeXt and Vision Transformers to observe how they measure classifying gastrointestinal diseases. This study ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Intraperitoneal (i.p.) injection is a common route for parenteral administration of drugs in laboratory rodents. The i.p. technique allows for the deposition of substances into the peritoneal cavity, ...

Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP), its second indication after severe asthma. The anti-TSLP antibody has ...

The gold standard for colorectal cancer screening is a colonoscopy. That’s because during the procedure, precancerous polyps can be removed if discovered, or cancer can be diagnosed if found. However, ...

Nasal polyps are common, usually noncancerous growths in the nose or sinuses. They can cause symptoms such as itching, runny nose, sneezing, and breathing trouble. Home remedies like a neti pot (nasal ...

A recent survey of patients, primary physicians and gastroenterologists found that an overwhelming majority prefer endoscopic polypectomy for small polyps detected by screening CT colonography. These ...

This guidance updates and replaces NICE technology appraisal guidance on dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal; TA648). Next review: This guidance will ...